Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors
Public ClinicalTrials.gov record NCT01231932. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Background: \- Fatigue is a common side effect of cancer and its treatment. Up to 96% of patients with cancer have fatigue. The cause of fatigue in people with cancer or those receiving treatment is poorly understood, making fatigue hard to treat. More research is necessary to understand why cancer patients experience fatigue. Previous research has shown that fatigue may be caused by a number of factors, including problems with the immune system response of the body while undergoing cancer treatment. The researchers of this study are trying to understand how the immune system and other chemicals of the body change while a person receives cancer treatment and how these changes play a role in causing fatigue. The researchers are also interested in how a person s quality of life is affected by fatigue. Objectives: \- To study fatigue in individuals who have cancer, are receiving cancer treatment, or have completed cancer treatment. Eligibility: * Individuals at least 18 years of age. * Receiving cancer treatment, OR completed primary treatment for cancer (e.g., cancer survivors), OR on active surveillance for localized cancer. Design: * This study involves an initial screening visit and up to three outpatient visits. * Participants will be screened with a medical history review (can be done virtually) and blood tests. A physical exam might also occur. * Participants undergoing cancer treatment that has a clear completion date, will have the following visits: * Before the start of treatment. * At the end of treatment. * At least 3 months after treatment ends. * Participants not receiving treatment, are cancer survivors, or undergoing cancer treatment that does not have a clear completion date, will have up to 3 visits: * Before the start of treatment or whenever you begin the study. * At least 3 months after your first visit. * At least 3 months after your second visit. * At each study visit, participants will complete the following tasks (some of the tasks can be done from home or virtually): * Questionnaires about physical activity, fatigue, depression, and quality of life (can be done at home or virtually). * Have blood drawn. * Physical activity device and journals to study how fatigue affects physical activity. * Optional tests: * Computer games testing your memory, attention, and ability to follow directions. * Hand grip strength test to evaluate physical strength. * Treatment will not be provided under this study.
Study identification
- NCT ID
- NCT01231932
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 163 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years to 120 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 3, 2011
- Primary completion
- Oct 31, 2024
- Completion
- Apr 15, 2025
- Last update posted
- Jun 18, 2025
2011 – 2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cancer trials
Other public records listing Cancer. Sorted by last update posted; newest first. Not a recommendation.
- NCT07796347: Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Alzheimer's Disease and Related Dementias and Their Caregivers Not yet recruiting
- NCT07788339: Keep Social Randomized Controlled Trial for Young Adults With Cancer Not yet recruiting
- NCT07787806: A Randomized Controlled Trial to Compare the Effectiveness of a Patient-reported Outcomes-driven Supportive Care Navigation Among Hispanic/Latinx Cancer Patients Not yet recruiting
- NCT07524218: Effect of Meal Timing During Adjuvant Treatment for Cancer Recruiting
- NCT07780903: A Study of a Digital Program for Helping Young Adult Cancer Survivors Learn About Financial Issues Related to Healthcare Recruiting
- NCT07776964: Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE) Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01231932, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2025 · Synced Sep 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01231932 live on ClinicalTrials.gov.